As with all such trials, we can hope.
The T3-4-Hypo trial
A Dutch national randomized placebo-controlled double-blind multicenter trial of LT4/LT3 combination therapy in patients with autoimmune hypothyroidism.
I note that the criteria specify "assay-specific reference ranges" for TSH. At last! A trial that formally recognises assay variations.